期刊文献+

SALL4基因在宫颈癌、宫颈上皮内瘤变组织和血浆中表达的研究 被引量:2

Expression and clinical significance of SALL4 gene in cervical cancer and cervical intraepithelial neoplasia
下载PDF
导出
摘要 目的:研究SALL4基因在宫颈癌、宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)组织和血浆中的表达情况并探讨其意义。方法:采用实时定量PCR方法检测56例宫颈癌患者、120例CIN患者组织和血浆中SALL4 mRNA的表达,以35例正常宫颈及慢性宫颈炎组织和血浆作为对照,分析宫颈癌组织和血浆中SALL4 mRNA相对表达量的相关性。并用ELISA方法检测各组血浆中SALL4水平。结果:对照组、CINⅠ组、CINⅡ~Ⅲ组、宫颈癌组组织中SALL4 mRNA相对表达水平分别为(4.58±0.64)×10-4、(6.86±0.72)×10-4、(27.03±2.85)×10-4、(40.8±5.50)×10-4,血浆中SALL4 mRNA相对表达水平分别为(0.14±0.05)×10-4、(0.16±0.07)×10-4、(0.49±0.08)×10-4、(2.18±0.22)×10-4,血浆中SALL4的浓度分别为(237±45)μg/L、(256±59)μg/L、(713±62)μg/L、(1 135±107)μg/L,随着病变的逐步进展,SALL4的表达逐渐增强,其中SALL4在宫颈癌组中的表达显著增强,与其他各组比较,差异有统计学意义(P〈0.01).宫颈癌组组织和血浆中SALL4 mRNA的相对表达水平正相关(r=0.684,P〈0.01)。结论:SALL4基因在CIN、宫颈癌组织和血浆中表达上调,可能在宫颈癌发生、发展中起一定作用。 Objective:To investigate the expression pattern and significance of SALL4 gene in CIN and cervical cancer. Methods: The expression of SALL4 mRNA in tissues and plasma of 56 cases of cervical cancer,120 cases of CIN,35 cases of normal cervical or chronic cervicitis(control group) was detected by Real-time PCR. The correlation analysis was conducted to assess the relationship between SALL4 expression in tissues and plasma of cervical cancer group. The levels of SALL4 in plasma were detected by enzyme linked immunosorbent assay. Results:The tissue levels of SALL4 mRNA expression in the the control group,CINⅠ group,CINⅡ~Ⅲ group and cervical cancer group were(4.58 ± 0.64) ×10-4,(6.86 ± 0.72)×10-4,(27.03 ± 2.85)×10-4and(40.8 ± 5.50)×10-4. The plasma levels of SALL4 mRNA expression were(0.14 ± 0.05)×10-4,(0.16 ± 0.07)×10-4,(0.49 ± 0.08)×10-4and(2.18 ± 0.22)×10-4. The concentration of SALL4 in plasma were(237 ± 45)μg / L,(256 ± 59)μg / L,(713 ± 62)μg / L and(1 135 ± 107)μg / L, respectively. With the progress of cervical disease,the expression of SALL4 was increasing gradually,the expression of SALL4 in cervical cancer group was higher than that in other groups(P 0.01). A positive correlation between SALL4 expression in tissues and plasma was observed in cervical cancer group(r = 0.684,P 0.01).Conclusion: SALL4 expression was up-regulated in the CIN and cervical cancer tissues and plasma,and it may be probably associated with the initiation,progression of cervical cancer..
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第2期188-191,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 常州市科技计划指导性项目(CY20120018) 常州市卫生局指导性科技项目(WZ201120)
关键词 SALL4基因 宫颈癌 宫颈上皮内瘤变 实时定量PCR 酶联免疫吸附试验 SALL4 gene cervical cancer cervical intraepithelial neoplasia real-time PCR ELISA
  • 相关文献

参考文献2

二级参考文献141

  • 11,Richart RMA.modifiedterminology for cervical intraepithial neoplasia.Obstet Gynecol,1990;75:131-133 被引量:1
  • 2郑顺娇.早期宫颈鳞癌癌灶的部位、分型、移行区的分类及组织发生学的病理探讨[J].中华病理学杂志,1989,18:231-232. 被引量:2
  • 3Bernards R. Cancer: cues for migration. Nature 2003; 425:247-248. 被引量:1
  • 4Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6:459-469. 被引量:1
  • 5Liang Z, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308. 被引量:1
  • 6John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23. 被引量:1
  • 7Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835. 被引量:1
  • 8Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol2005; 25:8581-8591. 被引量:1
  • 9Chinni SR, Sivalogan S, Dong Z, et al. CXCL 12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Prostate 2006; 66:32-48. 被引量:1
  • 10Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109:625-637. 被引量:1

共引文献89

同被引文献46

  • 1张艳,李宁丽.人类乳头瘤病毒免疫致病机制[J].现代免疫学,2006,26(6):523-526. 被引量:15
  • 2De Celis JF,Bar ri o R. Regulation and function of Spalt proteinsduring animal development[J]. Int J Dev B i o l , 2 0 0 9 , 5 3(8/9/10):1385-1398. 被引量:1
  • 3Sweetman D,Munsterberg A. The vertebrate spalt genes indevelopment and disease[J]. Dev B i ol , 2 0 0 6 , 2 9 3 ( 2 ):285-293. 被引量:1
  • 4Basson M, Horvitz HR. The caenorhabditis elegans gene sem-4controls neuronal and mesodermal cell development and encodes azinc finger protein[J]. Genes Dev, 1996, 10(15): 1953-1965. 被引量:1
  • 5Sung CK, Li D , Andrews E , et al. Promoter methylation of theSALL2 tumor suppressor gene in ovarian cancers[J]. MolOncol,2013,7(3):419-427. 被引量:1
  • 6Jemal A , Siegel R , Ward E , et al. Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96. 被引量:1
  • 7Ferlay J , Soerjomataram I , Dikshit R , et al. Cancer incidenceand mortality worldwide : Sources, methods and major patterns inGLOBOCAN 2012[J]. Int J Cancer,2015,136(6): 359-386. 被引量:1
  • 8Bosch FX, Burchell A , Schiffman M, et al. Epidemiology andnatural history of human papillomavirus infections and typespecificimplications in cervical neoplasia[J]. Vaccine,2008,26(10):1-16. 被引量:1
  • 9Naucler P , Ryd W , Tornberg S , et al. Efficacy of HPV DNAtesting with cytology triage and/or repeat HPV DNA testing inprimary cervical cancer screening[J]. J Natl Cancer Inst,2009,101(2):88-99. 被引量:1
  • 10Li D , Tian Y , Ma Y , et al. p150(Sal2) is a p53-independentregulator of p21(WAF1/CIP)[J]. Mol Cell Biol,2004,24(9):3885-3893. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部